Breast cancer: from “maximum tolerable” to “minimum effective” treatment

  • Veronesi U
  • Stafyla V
  • Luini A
  • et al.
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Randomized trials have played a fundamental role in identifying better treatments for most type of diseases, especially in the oncological field. In breast cancer, the shift from "maximum tolerable" to "minimum effective" treatment has been evident since the 1970s and has been based on the results of international randomized trials. The progress of breast surgery represents an excellent model of the evolution of science and the aim of this article is to review the main randomized studies that changed everyday practice in breast surgery.

Cite

CITATION STYLE

APA

Veronesi, U., Stafyla, V., Luini, A., & Veronesi, P. (2012). Breast cancer: from “maximum tolerable” to “minimum effective” treatment. Frontiers in Oncology, 2. https://doi.org/10.3389/fonc.2012.00125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free